Arabinogalactan derivatives and uses thereof
AssigneeAdvanced Magnetics, Inc.
InventorsChu Jung, Philip Enriquez, Stephen Palmacci, Lee Josephson, Jerome M. Lewis
Life of this patent
Estimating the term…
Abstract
A substantially purified arabinogalactan, its degradative products and selected modifications thereof have been found to act as carriers for delivering therapeutic agent to cell receptors capable of receptor mediated endocytosis (RME). The arabinogalactan and its degrative products once derivatived are capable of forming a complex between the therapeutic agent and the polysaccharide such that the complex retains the ability to recognize and bind to the RME receptor.
Claims6
A carrier capable of being attached to a therapeutic agent for the delivery thereof to a cell receptor capable of performing receptor mediated endocytosis (RME), comprising:
- a composition selected from the group consisting of substantially purified arabinogalactan and degradation products thereof,
- such composition modified at a site by a functional residue to produce a derivative in a manner that reserves the useful affinity of the derivative for the RME cell receptor, Wherein said functional residue is selected from the group consisting of phosphoryl, sulfhydryl, amino, halo, acylimidazole, carboxyl groups and a polymeric molecule, the derivative permitting further reactions of the derivative for attaching a therapeutic agent thereto.
Dependencies are inferred from the claim text.